Dosidal · Belgium

Maalox Antacid 230 mg/10 ml - 400 mg/10 ml

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketBelgium
Recordbe:presentation:cti:047476-02 (version 1)
Levelpresentation
Pack codebe-cnk (Belgian national): 0609727
Identifiersbe-cti-extended: 047476-02
be-cnk: 0609727
be-authorisation: BE047476
Source authorityFAMHP
Read date2026-11-15T03:58:09Z
authorisation statusamp_status: AUTHORIZED
ampp_status: AUTHORIZED
commercialised_now: False
lifecycle: current
period_from: 1971-12-01
supply_problem_now: False
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
controlled status
state: unknown
identityamp_code: SAM047476-00
atc: A02AB10
authorisation_number: BE047476
cti_extended: 047476-02
form: Oral suspension
holder: Opella Healthcare Belgium
medicine_type: ALLOPATHIC
name: Maalox Antacid 230 mg/10 ml - 400 mg/10 ml
pack: 355 ml
parallel_circuit: 0
parallel_import: False
substances: substance: Magnesium Hydroxide; substance: Aluminium Hydroxide
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
pack product codecnk_public: 0609727
fmd_in_scope: False
note: no FMD product code in SAM for this pack: the maker's GTIN is not published
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
prescription classas_published: Free delivery - Art 6, §1 bis, 1st paragraph, 2nd indent Law 25/03/1964 + Art 65, §3 Royal Decree 14/12/2006
class: non_prescription
delivery_modus: FD
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
l0AJgnE64v_YNXnM2x2MUD4eDOxyV-S2F5s0VU7LV_u-oUZkxXKZHlhZq-Mi8rtoXOYvqGbwdFbLF6bd3bgw_w
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/be:presentation:cti:047476-02 · Related records in other markets · Dosidal